Shannon Lam

Shannon focuses on developing and implementing strong patent strategies to advance her clients’ business goals and objectives.  She advises on global patent portfolio management, IP due diligence, competitive landscape analysis, IP agreements, and USPTO post-grant proceedings.  Whether a client is seeking investment, moving toward acquisition, or growing an existing portfolio, Shannon’s strategic guidance and counseling align with the objectives of a company’s life cycle at any stage.

Shannon’s clients range from fast-growth, emerging companies to major corporations in a variety of industries, including medical device, food & beverage, and consumer products.

Within the medical device industry, Shannon has worked extensively with cardiovascular, orthopedic, and ophthalmic technologies.  She has been involved in the intellectual property strategy and acquisitions of IDEV Technologies (acquired by Abbott), AccessClosure (acquired by Cardinal Health), Claret Medical (acquired by Boston Scientific), Tornier/Wright Medical (acquired by Stryker), and AcuFocus (acquired by Bausch + Lomb).  Shannon has also represented medical device companies in IPR proceedings before the Patent Trial and Appeal Board.

In addition to her depth of experience in medical device, Shannon has procured patents for family-owned businesses and managed global patent portfolios for Fortune 500 companies in the food & beverage and consumer products industries.  She provides IP counseling on acquisitions and agreements in which IP assets are central to the transactions.

Shannon was recently named among the “2023 Women Worth Watching® in STEM” by Profiles in Diversity Journal® and was recognized in The Legal 500 United States in 2023 and 2020 as being an outstanding practitioner. In 2023, she was also recognized as a "World IP Leader" by World Intellectual Property Review (WIPR).

Shannon is Chair of Knobbe Martens Mentor Committee and previously served as Co-Chair the firm’s Women Associates Advisory Committee.